Novocure (NVCR) Technical (Analysis) Reports Novocure ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Novocure (NVCR)
Technical Analysis Report for USA stock NVCR Novocure. Dated: 06 Feb 2026 Updated Daily. Stock trades under Health Care Deals in Medical Dental Instruments in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock NVCR Novocure then click here. or read Experts views on Novocure or Forecast & share price targets of Novocure
Novocure Opened at 10.34 and Closed at: 10.14, which is 0.49% of previous session's close. It moved within a range of 9.93 and 10.37
The session was a Bearish session with an average volume of 1850200, which is -188.1% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the long term trend of the stock remains negative and in a downtrend.
A Dead cross was found 4 days back on mid term averages
Support for tomorrow is 9.82 and resistance for tomorrow is 10.26
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 9.92, 9.71 resistance for tomorrow's hourly charts is 10.36, 10.59
10 Day SMA for Novocure (NVCR) is 11.95 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Novocure (NVCR) is 12.86 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Novocure (NVCR) is 12.91 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 12.91 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Novocure is 14.18 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Novocure is at 12.86 and 200 DMA is at 14.18, while 50 DMA and 100 DMA are at 12.91 and 12.91 respectively
Novocure (NVCR) moving average of 20 SMA is at 12.86 and 20 EMA is at 12.37
| Date | Closing Price | 20 SMA | 20 EMA |
| 06 Fri Feb | 10.14 | 12.86 | 12.37 |
| 05 Thu Feb | 10.09 | 13.09 | 12.61 |
| 04 Wed Feb | 11.56 | 13.31 | 12.87 |
| 03 Tue Feb | 11.84 | 13.44 | 13.01 |
| 02 Mon Feb | 12.19 | 13.54 | 13.13 |
| 30 Fri Jan | 12.40 | 13.59 | 13.23 |
Novocure (NVCR) moving average of 50 SMA is at 12.91 and 50 EMA is at 12.77
| Date | Closing Price | 50 SMA | 50 EMA |
| 06 Fri Feb | 10.14 | 12.91 | 12.77 |
| 05 Thu Feb | 10.09 | 12.96 | 12.88 |
| 04 Wed Feb | 11.56 | 13 | 12.99 |
| 03 Tue Feb | 11.84 | 13 | 13.05 |
| 02 Mon Feb | 12.19 | 12.99 | 13.1 |
| 30 Fri Jan | 12.40 | 12.97 | 13.14 |
Novocure (NVCR) moving average of 100 SMA is at 12.91 and 100 EMA is at 13.13
| Date | Closing Price | 100 SMA | 100 EMA |
| 06 Fri Feb | 10.14 | 12.91 | 13.13 |
| 05 Thu Feb | 10.09 | 12.94 | 13.19 |
| 04 Wed Feb | 11.56 | 12.96 | 13.25 |
| 03 Tue Feb | 11.84 | 12.97 | 13.28 |
| 02 Mon Feb | 12.19 | 12.98 | 13.31 |
| 30 Fri Jan | 12.40 | 12.98 | 13.33 |
Novocure (NVCR) moving average of 200 SMA is at 14.18 and 200 EMA is at 14.31
| Date | Closing Price | 200 SMA | 200 EMA |
| 06 Fri Feb | 10.14 | 14.18 | 14.31 |
| 05 Thu Feb | 10.09 | 14.2 | 14.35 |
| 04 Wed Feb | 11.56 | 14.23 | 14.39 |
| 03 Tue Feb | 11.84 | 14.25 | 14.42 |
| 02 Mon Feb | 12.19 | 14.27 | 14.45 |
| 30 Fri Jan | 12.40 | 14.29 | 14.47 |
Boston Scientific has performed better than Novocure in short term. You could have earned much better returns by investing in Boston Scientific, about 7.42% more returns!
Xtl Biopharmaceuticals has performed better than Novocure in short term. You could have earned much better returns by investing in Xtl Biopharmaceuticals, about 89.04% more returns!
Xenon Pharmaceuticals has performed better than Novocure in short term. You could have earned much better returns by investing in Xenon Pharmaceuticals, about 27.56% more returns!
Neuronetics Inc has performed better than Novocure in short term. You could have earned much better returns by investing in Neuronetics Inc, about 5.07% more returns!
Sonoma Pharmaceuticals has performed better than Novocure in short term. You could have earned much better returns by investing in Sonoma Pharmaceuticals, about 12.35% more returns!
Syndax Pharmaceuticals has performed better than Novocure in short term. You could have earned much better returns by investing in Syndax Pharmaceuticals, about 29.39% more returns!
Sellas Life has performed better than Novocure in short term. You could have earned much better returns by investing in Sellas Life, about 36.52% more returns!
Sol Gel has performed better than Novocure in short term. You could have earned much better returns by investing in Sol Gel, about 42.75% more returns!
Radnet Inc has performed better than Novocure in short term. You could have earned much better returns by investing in Radnet Inc, about 17.88% more returns!
Redhill Biopharma has performed better than Novocure in short term. You could have earned much better returns by investing in Redhill Biopharma, about 12.93% more returns!
Protagonist Therapeutics has performed better than Novocure in short term. You could have earned much better returns by investing in Protagonist Therapeutics, about 34.66% more returns!
Pulse Biosciences has performed better than Novocure in short term. You could have earned much better returns by investing in Pulse Biosciences, about 73.18% more returns!
Mesoblast has performed better than Novocure in short term. You could have earned much better returns by investing in Mesoblast, about 5.44% more returns!
Luminex Corporation has performed better than Novocure in short term. You could have earned much better returns by investing in Luminex Corporation, about 8.64% more returns!
Genesis Healthcare has performed better than Novocure in short term. You could have earned much better returns by investing in Genesis Healthcare, about 19.29% more returns!
Cytomx Therapeutics has performed better than Novocure in short term. You could have earned much better returns by investing in Cytomx Therapeutics, about 59.68% more returns!
Corcept Therapeutics has performed better than Novocure in short term. You could have earned much better returns by investing in Corcept Therapeutics, about 38.28% more returns!
Argenx Se has performed better than Novocure in short term. You could have earned much better returns by investing in Argenx Se, about 32.25% more returns!
Aldeyra Therapeutics has performed better than Novocure in short term. You could have earned much better returns by investing in Aldeyra Therapeutics, about 63.89% more returns!
Novocure Technical analysis of indicators
Price action analysis of Novocure (NVCR) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Novocure stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Novocure in short term and the sell signal is strong.
Novocure Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a SELL signal for Novocure in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Novocure is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 11.36 and Novocure NVCR stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Novocure NVCR stock. Volume based technical analysis of Novocure NVCR stock is negative.
Novocure Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock NVCR Novocure These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And NVCR Experts View which covers a lot of information including buying and selling signals
NVCR future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Novocure or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Novocure (NVCR) Technical (Analysis) Reports Novocure ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


